Vyome identifies itself as an innovation driven company which develops novel, first-in-class treatment options for significant unmet needs in Dermatology.
Vyome targets antibiotic resistant acne and other opportunist pathogens with its unique pipeline of drugs that retard antimicrobial resistance development.
Molecular Replacement Therapeutics (MRT) Based Products
Products for Treatment of Recalcitrant Skin Fungal Infections
For partnership queries, write to email@example.com.
Copyright © 2015 Vyome Biosciences. All rights reserved.